1 |
Strzelak A, Ratajczak A, Adamiec A, et al. Tobacco smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: A mechanistic review[J]. Int J Environ Res Public Health, 2018, 15(5): 1033.
|
2 |
Ma L, Huo X, Yang A, et al. Metal exposure, smoking, and the risk of COPD: A nested case-control study in a Chinese occupational population[J]. Int J Environ Res Public Health, 2022, 19(17): 10896.
|
3 |
Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019[J]. Eur Respir J, 2019, 53(5): 1900164.
|
4 |
Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-1717.
|
5 |
Fang L, Gao P, Bao H, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study[J]. Lancet Respir Med, 2018, 6(6): 421-430.
|
6 |
Agustí A, Celli BR, Criner GJ, et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary[J]. Am J Respir Crit Care Med, 2023, 61(4): 2300239.
|
7 |
Wan ES. The clinical spectrum of PRISm[J]. Am J Respir Crit Care Med, 2022, 206(5): 524-525
|
8 |
Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394(10204): 1145-1158.
|
9 |
钟南山, 曾广翘. 慢性呼吸疾病的防治策略[J]. 中国临床保健杂志, 2020, 23(1): 1-4.
|
10 |
Liang W, Yang Y, Gong S, et al. Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease[J]. Cell Host Microbe, 2023, 31(6): 1054-1070. e9.
|
11 |
Wu YK, Su WL, Yang MC, et al. Associations between physical activity, smoking status, and airflow obstruction and self-reported COPD: A population-based study[J]. Int J Chron Obstruct Pulmon Dis, 2022, 17: 1195-1204.
|
12 |
Lapperre, S, Postma DS, Gosman, MM, et al. Relation between duration of smoking cessation and bronchial inflammation in COPD[J]. Thorax, 61(2): 115-121.
|
13 |
Tantisuwat A, Thaveeratitham P. Effects of smoking on chest expansion, lung function, and respiratory muscle strength of youths[J]. J Phys Ther Sci, 26, 167-170.
|
14 |
Wan ES, Hokanson JE, Regan EA, et al. Significant spirometric transitions and preserved ratio impaired spirometry among ever smokers[J]. Chest, 2022, 161(3): 651-661.
|
15 |
Higbee DH, Granell R, Smith GD, et al. Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis[J]. Lancet Respir Med, 2022, 10(2): 149-157.
|
16 |
Wan ES, Balte P, Schwartz JE, et al. Association between preserved ratio impaired spirometry and clinical outcomes in US Adults[J]. JAMA, 2021, 326(22): 2287-2298.
|
17 |
Yin P, Jiang CQ, Cheng KK, et al. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study[J]. Lancet, 2007, 370(9589): 751-757.
|
18 |
陈荣昌, 梁振宇, 王凤燕. 我国慢性阻塞性肺疾病早期防控的现状、挑战与思考[J]. 中华健康管理学杂志, 2022, 16(2): 73-76.
|
19 |
张二明, 宋萍萍, 赵春燕, 等. 北京十家社区40岁以上居民肺通气功能调查及影响因素分析[J/OL]. 中华临床医师杂志(电子版), 2021, 15(5): 375-381.
|
20 |
孙培培, 张二明, 时延伟, 等. 北京市石景山区40岁及以上居民慢性阻塞性肺疾病患病情况及相关危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2023, 17(6): 711-719.
|